Compounds > n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea
Page last updated: 2024-09-03

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Neoplasm Metastasis

n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea has been researched along with Neoplasm Metastasis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chollet, P; Cure, H; D'Incan, M; Durando, X; Madelmont, JC; Mouret-Reynier, MA; Souteyrand, P; Thivat, E1
Chollet, P; D'Incan, M; Durando, X; Madelmont, JC; Sinsard, A; Thivat, E1
Barthomeuf, C; Cellarier, E; Chollet, P; D'Incan, M; Demidem, A; Durando, X; Farges, MC; Thivat, E; Vasson, MP1

Trials

2 trial(s) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Neoplasm Metastasis

ArticleYear
Second-line chemotherapy of disseminated malignant melanoma with cystemustine at 60 mg/m2: a phase II trial.
    Anti-cancer drugs, 2005, Volume: 16, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Neutropenia; Nitrosourea Compounds; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting

2005
Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial.
    Nutrition and cancer, 2008, Volume: 60, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Male; Melanoma; Methionine; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Nutritional Status; Oligodendroglioma; Patient Compliance; Treatment Outcome

2008

Other Studies

1 other study(ies) available for n'-(2-chloroethyl)-n-(2-(methylsulfonyl)ethyl)-n'-nitrosourea and Neoplasm Metastasis

ArticleYear
Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.
    BMC cancer, 2005, Nov-15, Volume: 5

    Topics: Adult; Antineoplastic Agents; Clinical Trials as Topic; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Remission Induction; Skin Neoplasms; Time Factors; Treatment Outcome

2005